Leveraging strategic partnerships to accelerate product development
The pressure to accelerate time-to-market for innovative pharmaceutical products has never been more intense. Every biopharmaceutical company – large and small – feels the need to drive promising therapies through development as quickly as possible to accelerate time to market and maximize the value of its assets. At the same time, current market and economic realities are compelling the industry to reduce fixed costs, increase efficiency, and concentrate limited resources on core competencies.
Many biopharmaceutical companies are exploring new types of strategic partnerships to help them achieve the flexibility, efficiency, and cost reductions they need to succeed in this difficult competitive environment. Leveraging strategic partnerships allows biopharmaceutical companies to greatly increase efficiency by focusing their internal resources on the highest priorities – such as discovery research and product marketing – while relying on their partners for a broad array of specialized knowledge and infrastructure, such as in-depth therapeutic-area expertise, clinical trial experience, global patient and investigator resources, and regulatory knowledge.
With over 28 years of experience as a leading CRO, PAREXEL is right where you need us to deliver the exact combination of development services you need to reduce the time and cost of bringing your products to market. Our experience conducting thousands of trials – from early phase trials through post-marketing studies – across the full spectrum of therapeutic areas gives our partners access to PAREXEL’s unsurpassed network of investigators and trial sites for faster study initiation. Our global resources give us the local knowledge and infrastructure to support your development needs anywhere in the world.
Our proven product development services include:
- Innovative biomarker analysis and development
- Complete clinical development services, Phases I-IV
- Advanced patient recruitment strategies
- Access to high-value investigators
- Extensive therapeutic area experience
- Integrated eClinical technologies
- Regulatory services for global submissions
- Safety/ pharmacovigilance program design and management
- Well-tested protocols and SOPs to support operational excellence